GlassScriptPhysician profile
Donald Taylor Bragg
NPI 1295789055
$7,626.48
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,928 · 2020: $3,258 · 2021: $860 · 2022: $567 · 2023: $13.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $2,621.93 | 2020-2022 | |
| Neotract INC. | $1,166.70 | 2019 | |
| Allergan, INC. | $787.93 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $750.85 | 2019-2021 | |
| Astellas Pharma US INC | $410.99 | 2019-2022 | |
| Abbvie INC. | $349.61 | 2019-2022 | |
| Urovant Sciences INC | $198.04 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $174.51 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $158.49 | 2019-2020 | |
| Coloplast Corp | $136.31 | 2019 | |
| Pfizer INC. | $104.20 | 2019-2022 | |
| Myovant Sciences INC. | $92.49 | 2021-2022 | |
| Blue Earth Diagnostics | $88.37 | 2019 | |
| Hollister Incorporated | $86.67 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $80.04 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $64.63 | 2019-2020 | |
| 180 Medical, INC. | $57.91 | 2021 | |
| Boston Scientific Corporation | $55.02 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $40.12 | 2021-2022 | |
| Mission Pharmacal Company | $27.66 | 2019-2021 | |
| Travere Therapeutics, INC. | $24.96 | 2019-2020 | |
| Medtronic, INC. | $19.39 | 2021 | |
| Genzyme Corporation | $19.30 | 2020 | |
| Rochester Medical Corporation | $18.80 | 2021 | |
| Amgen INC. | $18.40 | 2019 | |
| Convatec INC. | $18.07 | 2019 | |
| Janssen Biotech, INC. | $15.34 | 2019 | |
| Olympus America INC. | $14.24 | 2022 | |
| Axonics, INC. | $13.76 | 2023 | Axonics |
| Rgh Enterprises LLC | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Bragg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.